Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease: A Focus on Diabetes Mellitus as a High-Risk Patient Group

Potpara, Tatjana S. (57216792589)Tatjana S. (57216792589)PotparaLip, Gregory Y.H. (57216675273)Gregory Y.H. (57216675273)Lip2025-06-122025-06-122020https://doi.org/10.1161/CIRCULATIONAHA.120.046905https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086298296&doi=10.1161%2fCIRCULATIONAHA.120.046905&partnerID=40&md5=909045d374104c340ab7ff255b59825dhttps://remedy.med.bg.ac.rs/handle/123456789/4944[No abstract available]anticoagulantsatherosclerosisEditorialsplatelet aggregation inhibitorsCombining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease: A Focus on Diabetes Mellitus as a High-Risk Patient Group